|
|||||
|
|
Efficacy and safety of pegylated full‐length recombinant factor VIII with extended half‐life for perioperative haemostasis in haemophilia A patients |
|
| Authors: | B. Brand R. Gruppo T. T. Wynn L. Griskevicius M. F. Lopez Fernandez M. Chapman T. Dvorak B. G. Pavlova B. E. Abbuehl |
| Affiliation: | 1. Universitaetsspital Zuerich, Zuerich, Switzerland;2. Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA;3. College of Medicine, University of Florida, Gainesville, FL, USA;4. Vilnius University Hospital Santariskiu Klinikos, Medical Faculty of Vilnius University, Vilnius, Lithuania;5. Complejo Hospitalario Universitario A Coru?a, A Coru?a, Spain;6. Baxalta US Inc., Cambridge, MA, USA;7. Baxalta Innovations GmbH, Vienna, Austria |
| Abstract: | |
| Keywords: | extended half‐life haemophilia A pegylated recombinant factor VIII perioperative haemostasis |